Search

Search Constraints

You searched for: Author/Creator Igawa, Tsukasa

Search Results

2. Absolute lymphocyte count is an independent predictor of survival in patients with metastatic renal cell carcinoma treated with nivolumab. (5th October 2021)

4. Determining the optimal initial dose for Japanese patients with nocturnal polyuria using an initial dose of desmopressin 50 μg. Issue 3 (8th February 2023)

5. Growth inhibitory effect of an injectable hyaluronic acid–tyramine hydrogels incorporating human natural interferon-α and sorafenib on renal cell carcinoma cells. (1st January 2016)

6. Growth inhibitory effect of an injectable hyaluronic acid–tyramine hydrogels incorporating human natural interferon-α and sorafenib on renal cell carcinoma cells. (1st January 2016)

7. Immune-related adverse events are clinical biomarkers to predict favorable outcomes in advanced renal cell carcinoma treated with nivolumab plus ipilimumab. (10th February 2022)

8. Long-term response of over ten years with sorafenib monotherapy in metastatic renal cell carcinoma: a case report. (December 2016)

9. Paraganglioma of the urinary bladder: Case report and literature review. Issue 5 (4th July 2020)

10. Personalized peptide vaccination as second‐line treatment for metastatic upper tract urothelial carcinoma. Issue 12 (12th October 2017)